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Abstract 
The pain relief capabilities of salicylate are well established and a multitude of over the counter 
products populate pharmacy shelves. Over application of the preparations, through accidental 
or deliberate misuse, can all too often result in salicylate poisoning and, in severe cases, can be 
fatal. A novel detection strategy involving the quantification of the quinone byproducts arising 
from the electrochemical oxidation of salicylate is described. The approach has been adapted 
for use with a disposable screen-printed electrode and found to exhibit a high sensitivity 
towards salicylate which is free from the electroactive interferences that compromise the direct 
oxidative route. A linear range of 16 to 300 M was observed with a limit of detection of 5.6 
M. The analytical applicability of the approach was demonstrated through recovery 
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1.0 Introduction 
It has been estimated that, at any one time, some 10% of Americans suffer from acute or 
chronic pain – usually as a consequence of musculoskeletal injuries or disease [1-5]. Chronic pain 
can have a pernicious toll on everyday life placing considerable stress on the patient’s family, 
compromises workplace capability and responsibilities and is known to be one of the principal 
causes of physical disability[3]. Non steroidal anti-inflammatory drugs (NSAIDS), opioids or 
surgery are the conventional treatment options but, in many cases, these often fail to provide 
long-term benefit [5-7]. It is little surprise that many will seek alternative treatments and, as a 
result, there is a burgeoning market (>$100 million p.a.) in the supply of non-prescription over 
the counter (OTC) products that purport to provide a wealth of therapeutic benefits [8]. These 
take various forms such as pills, gels, ointments, lotions, sprays and, more recently, dressings 
and transdermal patches [9,10]. Salicylates are the active agent in a great many of these 
products but, as they can be readily acquired through sources that offer no qualified advice 
beyond the packaging instruction, issues over their efficacious application commonly arise [11]. 
While patient education and child protective caps have reduced instances of accidental misuse, 
data from the Toxic Exposures Survey from the American Association of Poison Control Centers 
(AAPCC) suggest that problems persist with 24% of analgesic-related deaths attributed to aspirin 
alone or in combination with other drugs. Early identification of salicylate poisoning can be life 
saving but, all too often, diagnosis is based on a host of secondary measurements [12,13]. The 
aim of the present communication has been to investigate the development of a modified 
screen printed sensor as a means of rapidly determining supratherapeutic doses of salicylate in 
urine. 
 
Under normal therapeutic regimes, the metabolism of salicylate will typically involve 
conjugation with glycine to form salicyluric acid and with glucuronic acid to form salicyl acyl and 
phenolic glucuronide as indicated in Scheme 1. Oxidation of the salicylate to gentisic acid (2,5-
dihydroxybenzoic acid), 2,3-dihydroxybenzoic and 2,3,5-trihydroxybenzoic acids can also occur 
but are minor in comparison to the other routes [14-16]. These metabolites are readily excreted 
in the urine with the unmodified salicylate accounting for 10-30%. The latter can rise 
significantly at large therapeutic loadings as both the glycine and glucuronide pathways have 
limited capacity and saturate easily [16]. The tissues become overwhelmed as a consequence 
and chronic salicylate toxicity can occur. It has been estimated that the plasma half-life for 
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salicylate is 2-3 h in low doses, increasing to 12 h at the more usual anti-inflammatory doses. In 
cases where supratherapeutic doses have been administered and salicylate intoxication occurs, 




Scheme 1. Typical reaction pathways for the metabolism of salicylic acid (SA) after administration of 
methyl salicylate(MS) or aspirin (ASA) from OTC preparations. SPG: Salicylic Acid Phenolic Glucuronide; 
SAG, Salicylic Acid Acyl Glucuronide; SU, Salicyluric Acid Phenolic Glucuronide.(Adapted from [13]). 
  
It is clear from the excretion pathways highlighted in Scheme 1 that there are several potential 
targets through which to assess salicylate concentration. Detection of the free, unconjugated 





The application of electrochemical techniques to the detection of salicylic acid has traditionally 
been beset by a number of issues – mainly the large anodic potentials required to oxidise the 
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analyte and the subsequent fouling of the electrode by oligomeric/polymeric oxidation 
products. A variety of approaches have been taken to minimise the effects of the latter and 
include: carbon electrodes [17], carbon with gold/iron oxide nanoparticles[18], gold electrodes 
coated with copper nanoparticles [19], platinum electrodes [20,21], screen printed electrodes 
[22], graphene based systems[23,24] and enzyme electrodes [25,26].  Park and Eun (2016) have 
postulated that while passivating polymeric films can arise, a number of additional products will 




Scheme 2. Potential product spread arising from the electro-oxidation of salicylate. PSA: polymeric 
deposits; GA: gentisic acid; DHBA: dihydroxybenzoic acid; BPSA: biphenylsalicylic acid (Adapted from [25]) 
 
The direct oxidation of salicylate under neutral or acidic pH conditions will require the 
imposition of large anodic potentials which, as result, could induce the oxidation of other 
sample components and thereby compromise the accuracy of any voltammetric measurements 
[27]. It could be envisaged that the byproducts (II-IV) could be oxidised (or reduced) at much 
lower potentials thereby offering the possibility of avoiding interference from other 
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electroactive species. The approach taken here was to examine the potential of using the 
electro-oxidation byproducts, principally the dimer BPSA, as a diagnostic marker through which 
to assess salicylate levels in urine.  
 
2.0 Experimental Details 
 
All chemicals were obtained from Sigma-Aldrich, were the highest grade available and were 
used without further purification. Electrochemical analysis was carried out using a VSP-300 
Multichannel Potentiostat / Galvanostat / EIS (Bio-Logic Science Instruments, EC-Lab Ltd) with a 
standard three-electrode configuration with a carbon screen printed working electrode, a 
platinum wire counter electrode and a standard silver/silver chloride (3M NaCl, BAS Technicol 
UK) reference electrode. All measurements were conducted at 22oC ± 2oC.  
 
Electrode Manufacture: Screen printed electrodes (SPE) were fabricated using a DEK 240 
Manual Screen Printing Machine, a stainless-steel screen mesh and graphite ink (Gwent 
Electronic Materials (GEM) Product code: C205010697). Initially, the base of the SPE was printed 
onto a Valox substrate which was cured at 70 °C for 90 min. To define the working area, a 
polymeric dielectric material (GEM Product code: D2071120P1) was then screen-printed onto 
the cured SPE. A JEOL JSM-6010 Plus scanning electron microscope (SEM) was used to 
characterise the surface morphology of the carbon sensors and representative micrograph of 
the carbon print morphology and the nanoporous nature of the deposit is highlighted in Figure 
1A. The electrode array and a digital image of the working electrode disc are shown in the inset 
figures. The surface profile was also characterised using a DEKTAK XT Stylus Profiler (Bruker) 
system and the results from three electrodes are compared in Figure 1B. The typical thickness of 
the print is of the order of 20 micron. In principle, the array could be harnessed for the 
electroanalytical detection of a panel of biomarkers through sequentially addressing each 
electrode in turn. In this instance however, the electrodes were used on an individual basis for 
the detection of salicylate.  
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Figure 1. A) Scanning electron micrograph of the carbon surface on the working electrode disc. Inset: 
Digital images of the complete printed array and the working electrodes. B) DEKTAK surface profile 
comparison of three working electrodes 
 
Electrode Anodisation: It has become relatively common to electrochemically anodise carbon 
composite electrodes in order to elicit improved electrochemical behaviour[28,29]. The electro-
oxidation (+2 V, 0.1 M NaOH) typically increases exfoliation of the carbon particles – generating 
more edge plane sites and increases the populations of various oxygen functional groups 
[28,29]. This process was also instituted here where it has been found that the unmodified 
screen printed electrodes typically exhibit poor electrochemical behaviour with large 
overpotentials necessary to obtain any significant analytical responses [28].  
 
Analytical Characterisation/Ethics Approval and Compliance: The analytical capability of the 
SPE sensors was assessed using human urine as the test matrix. Urine was obtained from four 
healthy volunteers (2M, 2F) who had not taken any form of medication in the 24 hours 
Page 7 of 19 
 
preceding collection of the samples and thus would be free of salicylate. The samples were 
collected, anonymised, stored at 4oC until required and then flushed to waste once the study 
had concluded. Approval for the use of human urine samples was granted through the Ulster 
University Ethics Committee (UREC Ref: REC/16/0073) prior to commencing the investigation.  
 
 
3.0 Results  
A square wave voltammogram detailing the response of an anodised screen printed 
electrode towards salicylate (290 M) in pH 7 buffer is shown in Figure 2. The peak observed at 
+0.86 V is attributed to the oxidation of the phenol functionality with the large potential and the 
relatively broad nature of the peak highlighting poor electron transfer at the carbon electrode. 
These attributes alone would be considered a significant impediment to the development of an 
electrochemical sensor based on the direct oxidation of salicylate and the issues are further 
highlighted when considering the application of the methodology in human urine. The 
responses of the anodised SPE towards urine before and after the addition of salicylic acid (290 
M) are presented in Figure 2 for direct comparison. A large, well defined peak dominates the 
profile at +0.36 V and is attributed to the oxidation of urate – a common component within 
urine.  It is important to note that beyond this initial urate peak, there is an increased 
background current with two further unassigned peaks at +0.51 V and +0.73 V resulting from 
the oxidation of compounds endogenous to the urine.  The introduction of the salicylate (dotted 
line) leads to a subtle change in the voltammetric profile and a new peak at +0.76 V arises. 
Analysis of the latter is complicated by the fact that its composition is due to the oxidation of 
multiple species and not simply salicylate itself. The variability in the background current arising 
from the presence of endogenous compounds poses a considerable challenge to the 
unambiguous quantification of salicylate through direct oxidation and it is clear that an 
alternative approach is required.  
The electrooxidation of the salicylate is known to lead to the production of 
hydroquinone species (GA, DHBA and BPSA etc) as indicated previously in Scheme 2. It could be 
anticipated that the latter should be capable of oxidation at lower potentials than the parent 
salicylate and therefore it was envisaged that through targeting these byproducts, an indirect 
measure of the initial salicylate concentration could be obtained which would be less 
susceptible to interference.  It has been suggested by Park and Eun that the hydroquinone dimer 
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(BPSA, structure IV in Scheme 2) is the predominate product of salicylate oxidation in alkaline 
solution [27] and therefore the efficacy of selecting this target/electrolyte combination as a 




Figure 2. Square wave voltammograms detailing the response of an anodised screen printed electrode 
towards human urine in the absence and presence of salicylic acid (290 M).  
 
3.1 Electrogenerated Dimer Detection 
Cyclic voltammetry was initially used to investigate the electrode processes arising from 
the oxidation of salicylic acid and to provide some diagnostic data on the subsequent 
electrogenerated byproducts. Voltammograms detailing the response of an anodised screen 
printed electrode towards the oxidation of salicylic acid (10 mM) in 0.1 M NaOH are detailed in 
Figure 3. The response recorded at an unmodified electrode are shown in the inset figure for 
comparison. The use of NaOH as the electrolyte was chosen as Park and Eun (2017) had 
previously shown that it minimises the build- up of polymeric material (I) and favours the 
production of the electrogenerated hydroquinones [27]. On the first scan, a single large 
oxidation peak is observed at +0.50 V resulting in the generation of radical cations that undergo 
further reaction to form the various products highlighted in Scheme 2. Given the potential 
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required to oxidise the salicylate, it can be anticipated that the resulting hydroquinones will be 
immediately oxidised and will be converted to the corresponding quinone forms (i.e. IV->V). 
Thus, on the reverse sweep, a series of reduction processes (+0.16 V and +0.25 V) can be 
observed leading to the reduction of the electrogenerated quinones back to the hydroquinone 
(V -> IV). The subsequent scans catch the hydroquinone-quinone redox transitions indicated 
within Scheme 3.  
 
 
Figure 3. Cyclic voltammograms detailing the response of an anodised screen printed electrode towards 
the oxidation of salicylic acid (10 mM, 0.1 M NaOH, 50 mV/s). Inset: Response of an unanodised electrode 
in the same solution and scan rate. 
 
Page 10 of 19 
 
 
Scheme 3. Hydroquinone-quinone redox transitions of the electrogenerated dimer resulting from the 
oxidation of salicylic acid. 
 
 
The voltammograms highlight the fact that the peak magnitude relating to the dimer byproduct 
(IV) is relatively small in comparison to the direct oxidation of the salicylic acid and this can be 
attributed to the product spread indicated in Scheme 2.   
 
3.2 Development of a Detection Methodology 
 
It can be seen from Figure 3 that the dimer only appears after the initial electrochemical 
oxidation of the salicylate. The oxidation and hence quantification of the dimer could be 
achieved through performing two simultaneous scans – one to generate the dimer and the 
second to detect it - but such an approach would clearly be clumsy from a procedural 
perspective. Rather than employing a positive potential sweep, the scan direction was simply 
reversed – starting at a potential sufficiently positive to induce the immediate oxidation of the 
salicylate and facilitate the production of the dimer. As mentioned previously, at the initial 
potential through which the hydroquinone dimer is formed, it will be simultaneously oxidised to 
its corresponding quinone form. As the potential sweeps to less positive potentials, it was 
envisaged that the dimer would be reduced back to the hydroquinone form and thereby provide 
the analytical signal. Given the challenge of detecting low quantities of salicylate in urine, the 
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higher sensitivity of square wave voltammetry was exploited as the principal instrumental 
technique. 
Square wave voltammograms detailing the initial oxidation of salicylate and the 
subsequent reverse sweep are shown in Figure 4. The oxidation of the salicylate to the radical 
cation commences immediately and as the scan progresses towards less positive potentials the 
re-reduction of the former is captured as an easily identifiable peak process at +0.57 V. As the 
sweep continues, a second reduction peak emerges at +0.19 V and this is attributed to the 
reduction of the electrochemically generated quinone dimer (IV). Increasing additions of 
salicylate to the test solution leads to the increase in the magnitude of both peak processes. The 
quinone dimer reduction was found to give a clear, well defined peak with a linear response 
over the range 16-300 M. It was envisaged that the low potential associated with the latter, 
rather than the direct reduction of the salicylate radical cation, would incur less interference 
from other matrix components. The sensitivity of the approach was found to be 0.0012 A/M 
with a detection limit of 5.6 M (based on 3s/b). It should be noted that the range and detection 
limit are sufficient for detecting free salicylate within urine at supratherapeutic doses and those 





Figure 4. Square wave voltammograms detailing the response of the anodised screen printed electrode 
towards increasing concentrations of salicylate (16 M increments) in 0.1M NaOH.  
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Electrodes used to assess quantification of the dimer were found to retain a response to the 
dimer when placed in fresh electrolyte devoid of any added salicylate indicating that there is an 
absorptive component in the interaction of the dimer with the anodised carbon surface. The 
possibility of solution carry-over was excluded through rigorous rinsing of the electrode 
configuration prior to commencing what should have been a blank scan. Despite such 
precautions, the dimer reduction peak at +0.19 V - exemplified in Figure 4 - was still observed 
albeit at a much lower intensity. The adsorptive interaction of the dimer at the carbon surface 
was further investigated using a higher concentration of the salicylate. An anodised screen 
printed electrode was scanned once in 10 mM salicylate in 0.1 M NaOH as per the scan 
parameters detailed previously (Figure 4). The electrode was removed and rinsed to remove 
excess salicylate solution. The electrode was then placed in fresh 0.1 M NaOH and square wave 
voltammograms recorded at 2 minute intervals. The responses obtained are detailed in Figure 
5A. On the first scan, it is notable that the peak associated with the reduction of the salicylate 
radical cation (+0.57 V) is greatly reduced and can be attributed to residual salicylate entrapped 
within the porous structure of the printed electrode (highlighted previously in Figure 1). As the 
potential is swept to less positive potentials, the reduction of the dimer is clearly observed. 
Again, it is worthwhile noting the relative magnitude of the peak in comparison to the residual 
salicylate. The magnitude of the dimer reduction process decreases with each consecutive scan 
and can be attributed to the gradual loss of the reduced form into the bulk of the solution.  
 
The process was repeated but, rather than monitor the loss of the dimer in NaOH, pH 7 
phosphate buffer was used. Similar peak processes were observed as those detailed in Figure 5A 
but the rate at which the peak decreased was markedly different and are compared in Figure 5B. 
The difference between the responses observed in NaOH and those in pH 7 buffer could be 
attributed to the effect of the prevailing pH on the solubility of the dimer. It was envisaged that 
upon reduction of the dimer to the hydroquinone form, the strong alkaline conditions would 
induce deprotonation of both the phenolic and carboxylate group with the charged nature of 
the molecule increasing its hydrophilicity and assist its loss to the bulk of the solution. In 
contrast, only the carboxylate will be deprotonated in pH 7 buffer (pKa of the phenol ~10) and 
thus the loss to the solution bulk will be slower. 
 




Figure 5. A) Consecutive square wave voltammograms detailing the response of an anodised SPE in 0.1 M 
NaOH after an initial scan in a solution containing 10 mM salicylic acid.  B) Influence of pH on dimer peak 
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3.3 Recovery of Salicylate in Human Urine 
 
The electroanalytical capability of the anodised screen-printed sensors within urine was 
investigated through assessing the recovery of 100 M salicylate within human urine. Square 
wave voltammetry was again adopted as the principal technique with the reduction of the dimer 
used as the analytical target. Urine was spiked with 100 M salicylate as standard addition 
protocol involving sequential additions of 50 M salicylate. The initial spike was chosen to 
reflect previous studies by Morra and coworkers looking at the percutaneous absorption of a 
salicylate ointment where the excretion of free salicylate in urine was found to be in the range 
of 15 mg/L (109 M) [30]. The test sample was 9 mL of 0.1 M NaOH followed by 1 mL of the 
urine / spike urine. It was necessary to retain the alkaline test medium to ensure the conversion 
of the dimer and to facilitate its desorption. A delay of 5 minutes was used between scans to 
ensure the latter did not influence subsequent scans. Representative voltammograms are 
detailed in Figure 6.  
 
 
Figure 6. Square wave voltammograms detailing the recovery of 100 M salicylate from human urine 
through the consecutive additions of 50 M Standard salicylate.  
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It is worthwhile noting that on the blank urine scan, there are no observable electrode 
processes within the potential window being examined. This is in marked contrast to the direct 
oxidation processes previously highlighted in Figure 2.  The analysis of the spiked urine results in 
a well defined peak – similar to those observed Figure 4. The recovery experiments were 
conducted in triplicate and the results obtained are summarised in Table 1.  It is clear from the 
responses observed in Figure 6 and the subsequent recovery experiments that the assay system 
proposed here can work within those limits with little interference from other endogenous 
components. 
 
Table 1. Recovery of 100 M Salicylate from Human Urine 
Sample Gender 
Recovery 
% N %RSD 
     1 F 99.98 3 0.61 
2 F 99.06 3 1.87 
3 M 99.81 3 3.22 
4 M 98.84 3 4.91 
     
      
An important observation from these investigations has been the relative lack of surface fouling 
– either as a consequence of the electrode processes or through non specific binding of other 
matrix components. The electrodes were left within the urine sample for upwards of 5 minutes 
during which time there was no noticeable deterioration in the response. In contrast, the 
standard addition procedure which required repetitive scanning of the same solution yielded 
excellent recovery of the spiked salicylate. Although the preliminary responses indicate no 
issues with surface fouling and that the electrodes could, in principle, be used for repeated 
measurements, it is envisaged that the final deployment would adopt a single use format similar 
to that used in portable glucose monitors.  
 
4.0 Discussion 
Patients attending Accident and Emergency services exhibiting a range of symptoms such as 
vomiting, abdominal pain, tinnitus, tachycardia and tachypnea could all too easily be suffering 
Page 16 of 19 
 
from salicylate poisoning[33-36]. The situation can be particularly complicated in paediatric 
cases where there can be a reluctance or inability of the subject to communicate. In many cases, 
the clinician will request a serum sample to determine the presence of salicylate as a matter of 
routine. This arises from the fact that, in many cases, the patient themselves may be unaware of 
the possibility of salicylate intoxication as the agent is commonplace in many OTC 
preparations[14,37] and there can be confusion over the correct application.  The use of 
qualitative urine tests based on either Ferric ion complexation or Trinder’s reagent has been 
advocated as a means of rapidly ascertaining whether salicylate poisoning is an underlying cause 
[33,36]. While the application of such tests could be beneficial it must be noted that their 
application can be contentious and procedurally problematic in a busy clinical emergency 
environment where there is often little opportunity to perform clinical chemistry. Moreover, the 
results can be subjective and subject to interference from other matric constituents giving rise 
to false positives[33]. Such issues can compromise clinician trust in such tests with a serum 
sample request being a default that effectively negates conducting the original spot test.   
 
It is little surprise therefore that there has long been considerable interest in the development 
of simple sensing systems that could rapidly detect salicylate and provide some quantitative 
measure of the latter concentration. In addition to the direct electrochemical systems 
mentioned previously, a large number of spectroscopic methodologies have been applied and 
have included: molecularly imprinted polymers based on fluorescent terbium complexes[38], 
macromolecular Schiff bases [39], silica-titania xerogels[40] and thiourea optodes[41]. These 
systems exhibit detection limits in the range of 10-4 to 10-7 M and hence are competitive with 
the printed electrode described here. It is the complexity of the competing systems and the lack 
of disposability however must be noted. Screen printed sensors are particularly amenable to 
mass manufacture and a large number of variants are commercially available (c.f. 
Dropsens.com). A critical advantage of the system advocated here is the fact that the sensor 
does not require extensive modification with nanoparticles [18,19], graphene [23,24] or 
enzymes [25]. The reagentless nature provides a procedurally simple solution with a clear 
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Conclusions 
The foundations of a sensor capable of quantifying salicylate within urine using an indirect 
methodology has been demonstrated. The system is reagentless and possesses sufficient 
sensitivity to enable the rapid assessment of supratherapeutic doses. Although the outcomes 
are preliminary in nature, the sensor has been shown to be free of the interferences that can 
hamper direct methods. The foundations of a simple system that can be used for the point of 
care assessment of salicylate level have been laid and could be a more reliable method than 
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